Companies: 10,795·Total market cap: $144.5T
Molina Healthcare, Inc.

Molina Healthcare, Inc.

MOHNYSEHealthcare● Active
$198.41
+$7.55(+3.96%)
Market Cap$10.3B
P/E Ratio
52W High$311.52
52W Low$121.06
Overview

Molina Healthcare, Inc. (MOH) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

moh · stock forecast · 38 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 38 Wall Street analysts in the past 3 months

SellBuy

Buy

38 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
17
Hold
15
Sell
6
Strong Sell
0
Total: 38 · Buy rate: 44.7%

12-Month Price Target

High

$224

Consensus

$174

-11.6% upside

Low

$124

Median: $165 · Last Close: $197.01

The Molina Healthcare, Inc. (MOH) analyst consensus is Buy, based on ratings from 38 Wall Street analysts over the past 3 months. The average 12-month MOH price target is $174.25, representing -11.6% upside from the current price of $197.01.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $174 (-11.6%)

Consensus Target

$174.25

-11.6% upside

High Target

$224

13.7%

Low Target

$124

-37.1%

Current Price

$197.01

as of today

Based on analyst price targets, the MOH stock price prediction for the next 12 months ranges from $124 to $224. The consensus MOH price forecast of $174.25 implies -11.6% upside from the current price of $197.01.

Short-Term Price Prediction

Bull

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$201.202.12%

1-day model range: $200.23–$202.17. Peak: $202.17 (+2.12%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$232+17.8%
2028$259+31.4%
2029$278+41.3%
2030$292+48.2%
2031+52.9%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BULLISH

Based on 14 technical indicators

93%7%0%
13Buy
1Neutral
0Sell
RSI (14)61.1Neutral
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · MOH · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$189.07BUY
MA 10$183.43BUY
MA 20$184.59BUY
MA 50$170.95BUY
MA 100$164.08BUY
MA 200$167.11BUY
Current $MOH · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$190.37BUY
EMA 10$186.97BUY
EMA 20$184.16BUY
EMA 50$175.41BUY
EMA 100$170.48BUY
EMA 200$181.41BUY
Current $MOH · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
Morgan Stanley2026-06-04
Maintains
Equal WeightEqual Weight
Barclays2026-05-26
Maintains
UnderweightUnderweight
UBS2026-05-22
Maintains
NeutralNeutral
Truist Securities2026-05-11
Maintains
HoldHold
Baird2026-05-11
Maintains
NeutralNeutral
Cantor Fitzgerald2026-05-11
Maintains
NeutralNeutral
Truist Securities2026-04-27
Maintains
HoldHold
Wells Fargo2026-04-27
Maintains
Equal WeightEqual Weight
UBS2026-04-24
Maintains
NeutralNeutral
Barclays2026-04-24
Maintains
UnderweightUnderweight

Wall Street analysts have recently issued updated ratings on Molina Healthcare, Inc. (MOH) stock. Of the recent 316 rating actions, 26 were upgrades and 24 were downgrades. 38 analysts currently cover MOH.

Analyst Recommendation Trends

Buy ratings101
Hold ratings01↑ +1
Sell ratings101

MOH analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$44.3B

↓ 11.1% YoY

Revenue Next Year

$47.7B

↑ 7.7% YoY

EPS This Year

$5.19

EPS Next Year

$9.29

↑ 79.2% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast MOH EPS of $5.19 for the current fiscal year, based on estimates from 11 analysts. The MOH revenue forecast is $44.3B for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The MOH stock forecast is supported by two independent data sources: analyst consensus ratings from 38 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus MOH price target is $174.25 (-11.6% upside), with an analyst consensus of Buy.

The MOH short-term stock prediction for tomorrow is $201.20 (+2.12%). The MOH stock price prediction for 2027 estimates an average of $232. The MOH stock prediction for 2030 projects a range of $277–$307.

Molina Healthcare, Inc. trades on NYSE under the ticker MOH. The MOH stock outlook for 2027 is broadly positive, supported by a Buy consensus among 45% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

MOH forecast · 8 questions

According to 38 Wall Street analysts, the average 12-month MOH price target is $174.25, with a high forecast of $224.00 and a low of $124.00. The median price target is shown in the chart above when available. This implies -11.6% potential upside from the current price of $197.01.

MOH price targetWhat is MOH price targetMOH analyst price targetMOH 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.